Oral ibandronate for the treatment of metastatic bone disease in breast cancer: efficacy an safety results from a randomized, double blind, placebo-controlled trial.
; ; ; ; ; ; (2004)
Please help us populate SUNScholar with the post print version of this article. It can be e-mailed to: firstname.lastname@example.org
Journal Articles (subsidised)
- 2004 - Research Outputs